AbCellera Biologics Funding: $195M Raised, Series B (2020)
AbCellera Biologics is based in Vancouver, Canada. It has raised $195M in total funding. Latest round: Series B.
AbCellera Biologics funding overview
AbCellera Biologics is based in Vancouver, Canada. AbCellera Biologics has raised $195M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in May 2020. The round record for AbCellera Biologics runs through 2020; nothing later has been disclosed. Investors on record include Founders Fund, UpHonest Capital, Peter Thiel, Accel, Advancit Capital, Antler and 8 others. 14 distinct backers are named across the disclosed rounds.
Frequently asked about AbCellera Biologics funding
How much has AbCellera Biologics raised?
AbCellera Biologics has raised $195M in total disclosed funding across the rounds on record.
Who has invested in AbCellera Biologics?
Founders Fund, UpHonest Capital, Peter Thiel, Accel, Advancit Capital, Antler are named among the investors backing AbCellera Biologics.
What was the latest AbCellera Biologics funding round?
The most recent disclosed round is a Series B, announced in May 2020.
Where is AbCellera Biologics based?
AbCellera Biologics is based in Vancouver, Canada.
When did AbCellera Biologics last raise?
The last disclosed AbCellera Biologics round closed in May 2020 at Series B.
We update the AbCellera Biologics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Vancouver and their backers are listed below.
